226 related articles for article (PubMed ID: 28472754)
1. Ruthenium(II) polypyridyl complexes: Synthesis, characterization and anticancer activity studies on BEL-7402 cells.
Wan D; Lai SH; Zeng CC; Zhang C; Tang B; Liu YJ
J Inorg Biochem; 2017 Aug; 173():1-11. PubMed ID: 28472754
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells.
Zeng CC; Jiang GB; Lai SH; Zhang C; Yin H; Tang B; Wan D; Liu YJ
J Photochem Photobiol B; 2016 Aug; 161():295-303. PubMed ID: 27288660
[TBL] [Abstract][Full Text] [Related]
3. Ruthenium(II) polypyridyl complexes induce BEL-7402 cell apoptosis by ROS-mediated mitochondrial pathway.
Jiang GB; Zheng X; Yao JH; Han BJ; Li W; Wang J; Huang HL; Liu YJ
J Inorg Biochem; 2014 Dec; 141():170-179. PubMed ID: 25268891
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of anticancer activity of ruthenium (II) polypyridyl complexes.
Tang B; Wan D; Lai SH; Yang HH; Zhang C; Wang XZ; Zeng CC; Liu YJ
J Inorg Biochem; 2017 Aug; 173():93-104. PubMed ID: 28511064
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, in vitro cytotoxicity and anticancer effects of ruthenium(II) complexes on BEL-7402 cells.
Zhang C; Han BJ; Zeng CC; Lai SH; Li W; Tang B; Wan D; Jiang GB; Liu YJ
J Inorg Biochem; 2016 Apr; 157():62-72. PubMed ID: 26828285
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and anticancer effect of the ruthenium (II) polypyridyl complexes on HepG2 cells.
Wan D; Lai SH; Yang HH; Tang B; Zhang C; Yin H; Zeng CC; Liu YJ
J Photochem Photobiol B; 2016 Dec; 165():246-255. PubMed ID: 27816647
[TBL] [Abstract][Full Text] [Related]
7. Protein binding and anticancer activity studies of ruthenium(II) polypyridyl complexes toward BEL-7402 cells.
Lai SH; Li W; Yao JH; Han BJ; Jiang GB; Zhang C; Zeng CC; Liu YJ
J Photochem Photobiol B; 2016 May; 158():39-48. PubMed ID: 26945645
[TBL] [Abstract][Full Text] [Related]
8. The induction of apoptosis in HepG-2 cells by ruthenium(II) complexes through an intrinsic ROS-mediated mitochondrial dysfunction pathway.
Zeng CC; Lai SH; Yao JH; Zhang C; Yin H; Li W; Han BJ; Liu YJ
Eur J Med Chem; 2016 Oct; 122():118-126. PubMed ID: 27344489
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption.
Wan D; Tang B; Wang YJ; Guo BH; Yin H; Yi QY; Liu YJ
Eur J Med Chem; 2017 Oct; 139():180-190. PubMed ID: 28800456
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of new ruthenium polypyridyl complexes with potent antitumor activity in vitro.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Sep; 220():117132. PubMed ID: 31146211
[TBL] [Abstract][Full Text] [Related]
11. Protein-binding, cytotoxicity in vitro and cell cycle arrest of ruthenium(II) polypyridyl complexes.
Liu SH; Zhu JW; Xu HH; Wang Y; Liu YM; Liang JB; Zhang GQ; Cao DH; Lin YY; Wu Y; Guo QF
Spectrochim Acta A Mol Biomol Spectrosc; 2016 May; 161():77-82. PubMed ID: 26956530
[TBL] [Abstract][Full Text] [Related]
12. The induction of apoptosis in SGC-7901 cells through the ROS-mediated mitochondrial dysfunction pathway by a Ir(III) complex.
Zhang C; Lai SH; Zeng CC; Tang B; Wan D; Xing DG; Liu YJ
J Biol Inorg Chem; 2016 Dec; 21(8):1047-1060. PubMed ID: 27796592
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity, apoptosis, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential, and Western blotting analysis of ruthenium(II) complexes.
Lin GJ; Jiang GB; Xie YY; Huang HL; Liang ZH; Liu YJ
J Biol Inorg Chem; 2013 Dec; 18(8):873-82. PubMed ID: 23989405
[TBL] [Abstract][Full Text] [Related]
14. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
[TBL] [Abstract][Full Text] [Related]
15. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic activity, DNA damage, cellular uptake, apoptosis and western blot analysis of ruthenium(II) polypyridyl complex against human lung decarcinoma A549 cell.
Lai SH; Jiang GB; Yao JH; Li W; Han BJ; Zhang C; Zeng CC; Liu YJ
J Inorg Biochem; 2015 Nov; 152():1-9. PubMed ID: 26291582
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, anticancer efficacy evaluation of ruthenium(II) and iridium(III) polypyridyl complexes toward A549 cells.
Liang L; Yang Y; Liu H; Yuan F; Yuan Y; Li W; Huang C; Chen J; Liu Y
J Biol Inorg Chem; 2023 Jun; 28(4):421-437. PubMed ID: 37097484
[TBL] [Abstract][Full Text] [Related]
18. Anticancer activity studies of a ruthenium(II) polypyridyl complex against human hepatocellular (BEL-7402) cells.
Li W; Han BJ; Yao JH; Jiang GB; Lin GJ; Xie YY; Huang HL; Liu YJ
Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():127-34. PubMed ID: 26037497
[TBL] [Abstract][Full Text] [Related]
19. Ruthenium(II) complexes: DNA-binding, cytotoxicity, apoptosis, cellular localization, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential and western blot analysis.
Li W; Jiang GB; Yao JH; Wang XZ; Wang J; Han BJ; Xie YY; Lin GJ; Huang HL; Liu YJ
J Photochem Photobiol B; 2014 Nov; 140():94-104. PubMed ID: 25108205
[TBL] [Abstract][Full Text] [Related]
20. Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2020 Jul; 208():111104. PubMed ID: 32485635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
